NCT01208948View on ClinicalTrials.gov

Clinical Trial on Alpha Lipoic Acid in Diabetic Macular Edema

PHASE3CompletedINTERVENTIONAL
Enrollment

520

Participants

Timeline

Start Date

July 31, 2000

Primary Completion Date

April 30, 2005

Study Completion Date

December 31, 2005

Conditions
Diabetes MellitusMacular Edema
Interventions
DRUG

1,2 dithiolane 3 valeric acid

600 mg alpha lipoic acid per day

Trial Locations (1)

80336

Department of Ophthalmology, Munich

All Listed Sponsors
collaborator

Bausch & Lomb Incorporated

INDUSTRY

lead

Ludwig-Maximilians - University of Munich

OTHER

NCT01208948 - Clinical Trial on Alpha Lipoic Acid in Diabetic Macular Edema | Biotech Hunter | Biotech Hunter